Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development organization supporting the pharmaceutical and biotechnology industries. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, ICH stability storage and testing, and cytotoxic & high-potency development. Many contract research organizations say they are client focused, few deliver.
Sequent Development is an independent CRO based in the U.S. that conducts preclinical drug studies in state-of-the art, GLP-certified research facilities in Kiev, Ukraine. Our research sites are sponsored by the Ukraine National Academy of Medical Sciences and Ministry of Health and offer support for commercial development of new drug discoveries as part of their core mission. Sequent was founded to bring the high quality, lower cost services of these research sites to emerging biotech companies in the U.S.
Pneumolabs is a privately held preclinical contract research services company. We offer a wealth of knowledge and experience of the primary, secondary and tertiary tests/ models required to progress compounds in the field of respiratory drug discovery.
Together with our preferred partners we provide a package of services from consultancy/advice, planning and study performance through to final reports. All of our services are on a highly interactive, rapid, flexible and confidential basis.
STATKING Clinical Services is proud of its over 20 year history of service to industrial and governmental clients. Since the company's founding in 1989, the company has evolved from providing statistical consulting and data analysis services on a variety of household products to a full service Contract Research Organization (CRO) serving the pharmaceutical and medical device industries.
Our company consists of people with high practical experience in EU regulatory affairs gained in Polish Authority and consulting companies. We are former Polish Authority experts who assessed dossier in national procedure, MRP, DCP, central procedure (EMEA/EMA) and were involved in preparation of Polish pharmaceutical regulations. We have practical experience in local law, knowledge of additional rules and requirements, EU guidelines interpretation and knowledge of the way how local Authorities really work which assures efficient services. We know the reality.
MaxCyte is a leader in cell transfection, bringing to market its patented flow electroporation technology. MaxCyte is focused in applying its significant capabilities in the discovery, development, and manufacturing of virtually all classes of innovative therapeutics targeting a broad range of chronic and acute diseases.
Medtronic is the world’s largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and extending life. Last year, more than 9 million people benefited from our medical therapies, which treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions.
Founded in 2004 in Rochester, New York, NaturalNano, Inc. develops unique and proprietary processes for refining naturally occurring nanotubes and other nanomaterials that add competitive properties to a range of applications. The Company's near-term goal is to make commercial quantities of high-quality naturally occurring nanotubes -- along with licenses based on the Company's proprietary technologies -- available for a wide variety of uses.